Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. - Wikidata - wikimedia - TriplyDB

Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb.

Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb.

http://www.wikidata.org/entity/Q33219845

about

Spatiotemporal control over growth factor signaling for therapeutic neovascularization Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review Highly angiogenic peptide nanofibers Diesel exhaust exposure induces angiogenesis Influence of poly(D,L-lactic-co-glycolic acid) microsphere degradation on arteriolar remodeling in the mouse dorsal skinfold window chamber.Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis.Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis.Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model Engineering complex tissues.Bioartificial matrices for therapeutic vascularization Cx37 deletion enhances vascular growth and facilitates ischemic limb recovery.A novel composite construct increases the vascularization potential of PEG hydrogels through the incorporation of large fibrin ribbons.Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones.Characterization of the arterial anatomy of the murine hindlimb: functional role in the design and understanding of ischemia models Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury Dental pulp and dentin tissue engineering and regeneration: advancement and challenge.Amniotic Mesenchymal Stem Cells Can Enhance Angiogenic Capacity via MMPs In Vitro and In Vivo.Effects of human vascular endothelial growth factor on reparative dentin formation.Temporally tunable, enzymatically responsive delivery of proangiogenic peptides from poly(ethylene glycol) hydrogels Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels Stromal cell identity influences the in vivo functionality of engineered capillary networks formed by co-delivery of endothelial cells and stromal cells.VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF.Biomimetic delivery with micro- and nanoparticles Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering.Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking.Update on therapeutic vascularization strategies.A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis Pulp and dentin tissue engineering and regeneration: current progress.Drug releasing systems in cardiovascular tissue engineering.A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors.Stem cell therapy - Hype or hope? A review.Delivery approaches for angiogenic growth factors in the treatment of ischemic conditions.Biodegradable Carriers for Delivery of VEGF Plasmid DNA for the Treatment of Critical Limb Ischemia.Design Advances in Particulate Systems for Biomedical Applications.Delivery of growth factor-based therapeutics in vascular diseases: Challenges and strategies.Treatment of hind limb ischemia using angiogenic peptide nanofibers Immobilization of glycoproteins, such as VEGF, on biodegradable substrates.Specific VEGF sequestering to biomaterials: influence of serum stability.Composite Scaffolds of Interfacial Polyelectrolyte Fibers for Temporally Controlled Release of Biomolecules.

P2860

Q24641819-3D7DC1EA-239F-4127-99AB-7CC4187A5577 Q26799856-A353C84F-252A-4FAD-90E3-5C1E38C18202 Q27334887-89085FAC-360D-4999-BB3E-7DA2EDE29D60 Q28392278-85032B0E-DB37-4720-B8DC-1AB878701658 Q30431749-A7D74F6C-1C8A-44C4-8921-9ADB9C2EAF11 Q30438396-776E5ED3-ED14-4EB2-B8FE-00D5B5185D50 Q33517020-DC252A78-3A6B-4E79-BBCB-DA483C7BD501 Q33617504-427E6D64-198A-41C0-BA71-8DAFBA98E5FD Q33650172-F16EBE8B-1EB3-40E5-B8E7-D860240C34AA Q33734474-61E9A34A-D4FA-4EC2-A7DB-226FFCF71A0B Q33998452-A38076D2-B1E7-4AC1-8E90-8B854EDE4C64 Q34086551-7AF11C9C-852C-438B-B7FA-C434FF8BE840 Q34241543-E1194688-AA7C-4248-8688-CADDBFD3DCCD Q35080805-F6A62A4D-3C1C-456E-828A-ADCF5FA698BE Q35303705-22984A2F-5291-4639-812A-6C098E17B21D Q35786383-C2EB9AD4-8594-4148-9A23-9365FB82BD41 Q36145009-AADE39B8-BE8D-4362-ABDD-AAB5CEA0CDCC Q36390236-62EB0554-CCCA-42EC-8318-948CEA6720DB Q36418634-54745B8F-EF17-4FFD-912B-B4DE655BC6E5 Q36623213-A5F27A93-E438-49C6-B78E-197211922D56 Q36720770-C91F9128-CDD9-4B5A-BE3C-6CD3EAB80F4D Q36752518-BD072739-D585-4205-9CEB-FC7EA4EC5462 Q36768786-B8D0F03E-617F-4C57-BBA0-8A003C56320D Q36870189-1A471B6A-2DDF-4B25-B5DA-C39367E34683 Q37121940-D76B3589-FE29-4907-85FF-9793893B16CA Q37182599-7C9528AD-1ABD-4119-9221-F9FEFAA685BC Q37357266-5F8F1D44-0AAE-44BD-80C8-AA9DE8A41437 Q37404262-AE78B21E-2D0D-495B-8391-8D1CCE7FA1E7 Q37447557-49E34E75-4498-484B-B646-8CE7501E579F Q37451635-C391B00B-1472-4D0C-A385-539ECF0160C5 Q37626478-61F7F4D5-58E1-4F65-9737-2AE26CC9B4EE Q37764704-926C2EC4-F36D-4F10-A236-70540AF35D2C Q37885356-F521A632-7160-4286-B385-4059F146CC2A Q38604899-C4A5028A-B6FB-4C2F-A326-63D076D594C6 Q38873026-1FA6B42D-2537-4E99-AA5A-1790F6066D5B Q39179993-0C2905D7-0005-4295-BCA9-551C2113B508 Q39763708-BCC879E6-5ED5-48C1-9606-20814DC9FB05 Q41643295-DB6917C8-886F-4100-8451-55EA55BBE044 Q42049840-61C0AAA4-69CE-453A-A206-573DC6E3F1B3 Q42145295-02F8E7DB-C10D-42CB-9666-1077E2046ABA

P2860

Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb.

http://www.wikidata.org/entity/Q33219845

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@ast

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@en

type

label

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@ast

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@en

prefLabel

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@ast

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@en

P1433

Q33219845-E6D76E1B-99FF-4DBA-9739-44A1981CBDF8

P1476

Q33219845-48B0D22E-E611-4DB3-8B09-9F972591416D

P2093

Q33219845-07F55957-D728-438F-A4FB-98AE035DE3AB

Q33219845-1F3489BE-5A3B-45B1-BC53-8920A94406E6

Q33219845-53A2BDA4-5AFE-4BAA-91BD-3F0B6E70C168

Q33219845-95107E70-834D-4935-B1BD-7ECF58905752

Q33219845-AD049836-751F-4BBE-B24B-1CBA34EEF117

Q33219845-D9C894FC-5CDB-4128-AB8A-B5FBE31FAB50

P2860

Q33219845-657DCE52-B5C5-4848-B197-42DEA298C279

Q33219845-88D693BC-D9A2-4416-9830-CB05C29D9A29

Q33219845-B81C12B6-62F3-4DC1-B22C-F4C196AA68C8

Q33219845-C5C274D5-C086-4E4E-8ECC-EC84A227E0CA

P304

Q33219845-7CBB8BB6-8609-440A-BE77-F4DA27169F5A

P31

Q33219845-06A552FA-52DD-44F3-9E6F-38754DCF4399

P356

Q33219845-29C26C85-5FED-4FD6-BD82-2F94C15443A0

P433

Q33219845-E1B72CA6-40E3-4882-9E20-79C1934FDD26

P478

Q33219845-1993228C-E389-4CFC-A682-B5912583531B

P577

Q33219845-2C077A11-B024-41DC-9DF5-E2B941E63B17

P5875

Q33219845-5ED15015-2A4C-4FCC-B21D-91803702D8DD

P698

Q33219845-D6A497CB-6577-4599-8382-5199A7409678

P921

Q33219845-272249B3-7540-4613-AA94-F4B71D35F3C2

P356

S11095-005-5644-2

P1433

Pharmaceutical Research

P1476

Sustained vascular endothelial ...... rfusion in ischemic hind limb.

@en

P2093

David J Mooney

http://www.w3.org/2001/XMLSchema#string

P Michael Grossman

http://www.w3.org/2001/XMLSchema#string

Qinghua Sun

http://www.w3.org/2001/XMLSchema#string

Ruth R Chen

http://www.w3.org/2001/XMLSchema#string

Sanjay Rajagopalan

http://www.w3.org/2001/XMLSchema#string

Yuechun Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Age-dependent impairment of angiogenesis.

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

P304

1110-1116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-005-5644-2

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7716943

http://www.w3.org/2001/XMLSchema#string

P698

16028011

http://www.w3.org/2001/XMLSchema#string

P921